Akebia Therapeutics Announces Poster Presentations and Educational Symposium at National Kidney Foundation 2021 Virtual Spring Clinical Meetings ...

Associations between heat exposure and potentially negative impacts on kidney function were recently identified in 2 studies presented at the National Kidney Foundation SCM25 Spring Clinical Meetings.

ORLANDO - Improving quality—and outcomes—in the dialysis setting requires multidisciplinary teamwork, said incoming National Kidney Foundation president Beth Piraino during her address ...

NKF SCM23 attendees can visit the Akebia booth (#801) in the Exhibit Hall. About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to ...

Akebia Therapeutics will present research on kidney disease treatment at the NKF SCM25 from April 10-13, 2025.

--Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the National Kidney ...